ProShares Ultra NASDAQ Biotechnology
24 hedge funds and large institutions have $3.62M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
4
Calls
$537K
Puts
$436K
Net Calls
+$101K
Net Calls Change
-$186K